XML 93 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (USD $)
Total
September 2013 Common Stock Offering [Member]
Long-term Debt Financing [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Additional Paid-in Capital [Member]
September 2013 Common Stock Offering [Member]
Additional Paid-in Capital [Member]
Long-term Debt Financing [Member]
Accumulated Other Comprehensive Income [Member]
Accumulated Deficit [Member]
Treasury Stock [Member]
Beginning balance at Dec. 31, 2010 $ 2,430,000     $ 2,000 $ 62,020,000     $ 0 $ (55,743,000) $ (3,849,000)
Beginning balance, shares at Dec. 31, 2010       19,047,759            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Issuance of common stock, shares       18,650,000            
Issuance of common stock 18,615,000     2,000 18,613,000          
Common stock warrants issued in connection with common stock offering (12,709,000)       (12,709,000)          
Issuance of stock in lieu of cash bonus, shares       147,040            
Issuance of stock in lieu of cash bonus 171,000       171,000          
Issuance of resticted stock units, shares       220,729            
Issuance of restricted stock units 256,000       256,000          
Issuance of common stock in exchange for services, shares       53,558            
Issuance of common stock in exchange for services 73,000       73,000          
Issuance of common stock upon exercise of warrants, shares       4,301,000            
Issuance of common stock upon exercise of warrants 3,270,000       3,270,000          
Issuance of common stock in connection with employee stock purchase plan, shares       18,824            
Issuance of common stock in connection with employee stock purchase plan 15,000       15,000          
Issuance of common stock in settlement of contingent purchase price consideration                     
Issuance of common stock in settlement of contingent purchase price consideration, shares       4,974,090            
Issuance of common stock related to acquisition 6,367,000     1,000 6,366,000          
Issuance of common stock subject to employee termination agreements, shares       398,453            
Issuance of common stock subject to employee termination agreements 350,000       350,000          
Stock based compensation for directors and employees 2,774,000       2,774,000          
Stock based compensation for services (15,000)       (15,000)          
Net liabilities distributed in connection with the RXi spin-off 0                  
Net loss (11,485,000)               (11,485,000)  
Ending balance at Dec. 31, 2011 10,112,000     5,000 81,184,000     0 (67,228,000) (3,849,000)
Ending balance, shares at Dec. 31, 2011       47,811,453            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Issuance of common stock, shares       25,486,960            
Issuance of common stock 36,378,000     2,000 36,376,000          
Common stock warrants issued in connection with common stock offering (7,286,000)       (7,286,000)          
Issuance of common stock in exchange for services, shares       288,285            
Issuance of common stock in exchange for services 364,000       364,000          
Issuance of common stock upon exercise of warrants, shares       8,433,003            
Issuance of common stock upon exercise of warrants 16,551,000     1,000 16,550,000          
Repurchase Of Common Stock Warrant (266,000)       (266,000)          
Issuance of common stock in connection with employee stock purchase plan, shares       234,350            
Issuance of common stock in connection with employee stock purchase plan 93,000       93,000          
Issuance of common stock in settlement of contingent purchase price consideration, shares       1,315,849            
Issuance of common stock in settlement of contingent purchase price consideration 1,579,000       1,579,000          
Stock based compensation for directors and employees 794,000       794,000          
Stock based compensation for services 600,000       600,000          
Net liabilities distributed in connection with the RXi spin-off 2,159,000       2,159,000          
Unrealized gain on marketable securities, net of tax 1,626,000             1,626,000    
Exercise of stock options, shares       25,937            
Exercise of stock options 21,000       21,000          
Net loss (34,969,000)               (34,969,000)  
Ending balance at Dec. 31, 2012 27,756,000     8,000 132,168,000     1,626,000 (102,197,000) (3,849,000)
Ending balance, shares at Dec. 31, 2012       83,595,837            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Issuance of common stock, shares       20,125,000            
Issuance of common stock 37,539,000     2,000 37,537,000          
Common stock warrants issued in connection with common stock offering   (8,238,000) 351,000     (8,238,000) 351,000      
Issuance of common stock upon exercise of warrants, shares       5,320,669            
Issuance of common stock upon exercise of warrants 22,064,000       22,064,000          
Issuance of common stock in connection with employee stock purchase plan, shares 243,510     52,532            
Issuance of common stock in connection with employee stock purchase plan 163,000       163,000          
Issuance of common stock in settlement of contingent purchase price consideration, shares       492,988            
Issuance of common stock in settlement of contingent purchase price consideration 1,247,000       1,247,000          
Issuance of common stock related to acquisition 0                  
Issuance of common stock in exchange for services, shares       99,998            
Issuance of common stock in exchange for services 211,000       211,000          
Stock based compensation for directors and employees 1,886,000       1,886,000          
Stock based compensation for services 644,000       644,000          
Net liabilities distributed in connection with the RXi spin-off 0                  
Reclassification of unrealized gain upon the sale of marketable securities, net of tax of $1,052 (1,626,000)             (1,626,000)    
Exercise of stock options, shares 289,000     413,677            
Exercise of stock options 567,000       567,000          
Net loss (76,678,000)               (76,678,000)  
Ending balance at Dec. 31, 2013 $ 5,886,000     $ 10,000 $ 188,600,000     $ 0 $ (178,875,000) $ (3,849,000)
Ending balance, shares at Dec. 31, 2013       110,100,701